CAB-LAcabotegravirF/TDF
…/TDF) were assessed by a multivariable logistic regression. For CAB-LA, injections were classified as on time (within ±7 days from the…
5articles mentioning drugs
28drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CAB-LA ×
CAB-LA
This drug is selected. Its supporting articles are shown below.
Articles mentioning CAB-LA
5 articles · page 1 of 1CAB-LAcabotegravirHIVANRS-PREVENIR
…persistence issues remain. Long-acting injectable cabotegravir (CAB-LA) is a promising new PrEP HIV prevention option. However, little…
87.7%
CAB-LAVisual Analogue ScaleHIV
…Background Long-acting cabotegravir (CAB-LA) is a key addition to HIV prevention but requires more resource…
CAB-LAcabotegravirGonorrhoeaChlamydiaHIVCBSPrEPPrEP-experienced
…ve access and persistence. Long-acting injectable cabotegravir (CAB-LA) has recently been introduced in some Italian clinical centres,…
cabotegravirCAB-LALEVIHIVHPTN Laboratory Center
…osis can be especially challenging in persons using long-acting cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) due to long-acting ear…